That is why the invitation extended by U.S. congressional leadership to the SPLM-IO’s acting chairman, Nathaniel Oyet, is a big deal. In South Sudan, outside engagement, especially with a ...
Despite significant R&D investments, pharma companies often underestimate the multifaceted challenges of bringing promising treatments to market – from securing favourable reimbursement to developing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results